Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Inhibitex Inc. (NASDAQ:INHX.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INHX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.75)
Submitted January 10, 2012

Even more than the lousy bets I did make in 2011, I regret failing to realize the potential of hepatitis C polymerase inhibitors to turn perennially weak companies like Inhibitex and Idenix into explosive winners. I did profit well from Anadys, but I… More

TMFUltraLong (94.93)
Submitted November 30, 2011

Definitely not feeling the Tulipmania buzz in the hepatitis C sector. Couldn't stand the premium that Gilead ponied up for Pharmasset and see even less of a chance of that happening to Inhibitex. Not even out of phase 2 clinical trials, yet a market… More

NASDAQ:INHX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about INHX.DL.

No one has written a Pitch for INHX.DL stock yet. Tell us why you think INHX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in INHX.DL.

No players have picked INHX.DL yet. Tell us why you think INHX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INHX.DL.